Efficacy of belimumab and targeting of rheumatoid factor-positive B-cell expansion in Sjögren's syndrome: follow-up after the end of the phase II open-label BELISS study. (Q50929875)
Jump to navigation
Jump to search
scientific article published on 9 February 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy of belimumab and targeting of rheumatoid factor-positive B-cell expansion in Sjögren's syndrome: follow-up after the end of the phase II open-label BELISS study. |
scientific article published on 9 February 2016 |
Statements
1 reference
Efficacy of belimumab and targeting of rheumatoid factor-positive B-cell expansion in Sjögren's syndrome: follow-up after the end of the phase II open-label BELISS study. (English)
1 reference
Luca Quartuccio
1 reference
Sara Salvin
1 reference
Laura Corazza
1 reference
Saviana Gandolfo
1 reference
Martina Fabris
1 reference
Salvatore De Vita
1 reference
9 February 2016
1 reference
34
1 reference
311-314
1 reference
2
1 reference
Identifiers
1 reference